Bausch Health Companies (BHC) had the highest return in 1995 by a US stock in the Pharmaceuticals Industry, returning 880.9%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Bausch Health Companies (BHC) | 1995 | 880.93% |
Teva Pharma Industries Ltd ADR (TEVA) | 1995 | 94.71% |
Eli Lilly and (LLY) | 1995 | 77.33% |
Merck (MRK) | 1995 | 77.18% |
Pfizer (PFE) | 1995 | 72.45% |
Johnson & Johnson (JNJ) | 1995 | 59.49% |
Bristol-Myers Squibb (BMY) | 1995 | 53.63% |
Novo Nordisk A-S (NVO) | 1995 | 47.71% |
AstraZeneca PLC ADR (AZN) | 1995 | 46.93% |
GlaxoSmithKline PLC ADR (GSK) | 1995 | 43.54% |
Viatris (VTRS) | 1995 | 31.81% |
Nektar Therapeutics (NKTR) | 1995 | 2.63% |
ProPhase Labs (PRPH) | 1995 | 0% |
Perrigo (PRGO) | 1995 | -4.04% |
